Intraepithelial Neoplasia Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Patients With Long Standing Ulcerative Colitis Undergoing Colonoscopy.
- endoscopically verified UC signed written informed consent
- Known or suspected GI obstruction or perforation Liver or renal impairment,
malignancy, pregnancy or lactation, suppressed PT.
Type of Study:
Observational Model: Case-Only, Time Perspective: Prospective
Intraepithelial neoplasia detection rate
Outcome Time Frame:
Italy: AIFA Agenzia Italiana del Farmaco
- Long Standing Ulcerative Colitis
- Colitis, Ulcerative
- Carcinoma in Situ